|
OMIM |
Link |
Information gain |
01 |
|
dermatitis, atopic
|
[NCBI]
|
0.00157894
|
|
|
RNASE3
|
[NCBI]
|
0.0012187
|
|
|
IGER
|
[NCBI]
|
0.00104635
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000904718
|
|
|
NCR
|
[NCBI]
|
0.000866698
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000866698
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.000813359
|
|
|
ATOD6
|
[NCBI]
|
0.000742146
|
|
|
IGES
|
[NCBI]
|
0.000656414
|
|
|
MS4A2
|
[NCBI]
|
0.00051953
|
|
|
IL4R
|
[NCBI]
|
0.000312612
|
|
|
NETH
|
[NCBI]
|
0.000221056
|
|
|
CF
|
[NCBI]
|
0.000179529
|
|
|
vibratory angioedema
|
[NCBI]
|
0.000117198
|
|
|
lymphoblastic transformation, intrinsic defect in
|
[NCBI]
|
0.000117198
|
|
|
retinal telangiectasia and hypogammaglobulinemia
|
[NCBI]
|
0.000117198
|
|
|
IL4
|
[NCBI]
|
9.53635e-05
|
|
|
RNASE2
|
[NCBI]
|
9.387e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
8.07696e-05
|
|
|
immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
|
[NCBI]
|
8.07696e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
8.07696e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
7.66853e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
7.34328e-05
|
|
|
C3AR1
|
[NCBI]
|
7.08523e-05
|
|
|
IL13
|
[NCBI]
|
6.70334e-05
|
|
|
THC1
|
[NCBI]
|
6.01878e-05
|
|
|
STAT6
|
[NCBI]
|
5.90965e-05
|
|
|
CCL22
|
[NCBI]
|
5.68018e-05
|
|
|
CCL17
|
[NCBI]
|
5.38078e-05
|
|
|
SART1
|
[NCBI]
|
5.1886e-05
|
|
|
FER
|
[NCBI]
|
5.1886e-05
|
|
|
CCL24
|
[NCBI]
|
5.1886e-05
|
|
|
FCER1A
|
[NCBI]
|
5.1886e-05
|
|
|
IL13RA1
|
[NCBI]
|
5.1886e-05
|
|
|
CLC
|
[NCBI]
|
4.85161e-05
|
|
|
PHF11
|
[NCBI]
|
4.85161e-05
|
|
|
GSTT1
|
[NCBI]
|
4.85161e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
4.81669e-05
|
|
|
CCL11
|
[NCBI]
|
4.60124e-05
|
|
|
GPR154
|
[NCBI]
|
4.60124e-05
|
|
|
MEN2B
|
[NCBI]
|
4.4928e-05
|
|
|
MPO
|
[NCBI]
|
4.33996e-05
|
|
|
ABP1
|
[NCBI]
|
4.25856e-05
|
|
|
LTA4H
|
[NCBI]
|
4.09451e-05
|
|
|
HDC
|
[NCBI]
|
4.05231e-05
|
|
|
HLA-G
|
[NCBI]
|
3.86083e-05
|
|
|
SPINK5
|
[NCBI]
|
3.67235e-05
|
|
|
GATA3
|
[NCBI]
|
3.67235e-05
|
|
|
IL9
|
[NCBI]
|
3.59021e-05
|
|
|
SLE
|
[NCBI]
|
3.4725e-05
|
|
|
LTC4S
|
[NCBI]
|
3.4442e-05
|
|
|
JAK1
|
[NCBI]
|
3.37867e-05
|
|
|
PLA2G7
|
[NCBI]
|
3.37867e-05
|
|
|
GSTP1
|
[NCBI]
|
3.37867e-05
|
|
|
GSTM1
|
[NCBI]
|
3.37867e-05
|
|
|
RIPK1
|
[NCBI]
|
3.31729e-05
|
|
|
IGKC
|
[NCBI]
|
3.31729e-05
|
|
|
IL5
|
[NCBI]
|
3.25958e-05
|
|
|
HNMT
|
[NCBI]
|
3.25958e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
2.89162e-05
|
|
|
CSF2
|
[NCBI]
|
2.81815e-05
|
|
|
SOCS3
|
[NCBI]
|
2.68632e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
2.68346e-05
|
|
|
JAK3
|
[NCBI]
|
2.49239e-05
|
|
|
CCR5
|
[NCBI]
|
2.19519e-05
|
|
|
PTGS2
|
[NCBI]
|
2.00009e-05
|
|
|
VIP
|
[NCBI]
|
1.87502e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.7512e-05
|
|
|
WAS
|
[NCBI]
|
1.17939e-05
|
|
|
VEGF
|
[NCBI]
|
1.05462e-05
|
|
|
IL2
|
[NCBI]
|
6.78702e-06
|
|
|
HP
|
[NCBI]
|
6.26506e-06
|
|
|
TLR4
|
[NCBI]
|
5.34987e-06
|
|
|
SPP1
|
[NCBI]
|
1.97508e-06
|
|
|
RA
|
[NCBI]
|
1.49898e-06
|
|
|
VDR
|
[NCBI]
|
8.95677e-07
|
|
|
TNFSF6
|
[NCBI]
|
4.34702e-07
|
|
|
NPY
|
[NCBI]
|
2.8539e-07
|
|
|
TNF
|
[NCBI]
|
2.18917e-07
|
|
|
NGFB
|
[NCBI]
|
5.77999e-08
|
|